PAVM PAVmed Inc.

NASDAQ
$5.20

PAVmed Inc. (PAVM) is expected to report earnings on November 13, 2026, before the market open. The consensus earnings estimate is a loss of $0.66 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.6% since its last earnings release on August 14, 2026.

PAVmed Beat Consensus Estimates
Friday, August 14, 2026 · 8:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 13
Friday · 8:00 AM ET
Earnings Whisper
-
vs ($0.66)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.00

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About PAVmed Inc.

PAVmed Inc. is a highly differentiated, multi-product, commercial-stage medical technology company with a diversified product pipeline addressing unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities.

Sector

Healthcare

Industry

Medical Instruments/Supply